[1]
S. S. N. KOTA and S. Bandhakavi, “COST-EFFECTIVENESS OF COMBINATION ANTI-CANCER DRUG THERAPY IN THE MANAGEMENT OF HER2-POSITIVE BREAST CANCER: A META-ANALYSIS”, Asian J Pharm Clin Res, vol. 16, no. 12, pp. 20–25, Dec. 2023.